Fecal microbiota transplantation broadening its application beyond intestinal disorders

World Journal of Gastroenterology

Volumn 21, Issue 1, 2015, Pages 102-111

  Xu, Meng Que ^a   Cao, Hai Long ^a   Wang, Wei Qiang ^a   Wang, Shan ^a   Cao, Xiao Cang ^a   Yan, Fang ^a,b   Wang, Bang Mao ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dysbiosis; Extra intestinal disorders; Fecal microbiota transplantation; Intestinal microbiota; Therapy

Indexed keywords

ALLERGIC DISEASE; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC FATIGUE SYNDROME; CONSTIPATION; DYSBIOSIS; ENTEROPATHY; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSULIN SENSITIVITY; INTESTINE FLORA; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; MYOCLONUS DYSTONIA; NEOPLASM; NONHUMAN; PARKINSON DISEASE; TRANSPLANTATION; ULCERATIVE COLITIS; ADVERSE EFFECTS; ANIMAL; BIOLOGICAL THERAPY; FECES; HOST PATHOGEN INTERACTION; INTESTINAL DISEASES; INTESTINE; MICROBIOLOGY; MICROFLORA; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL THERAPY; DYSBIOSIS; FECES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL DISEASES; INTESTINES; MICROBIOTA; TREATMENT OUTCOME;

EID: 84920931626     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i1.102     Document Type: Article

References (115)

1. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31: 107-133 [PMID: 334036 DOI: 10.1146/annurev.mi.31.100177.000543]
2. Salonen A, Palva A, de Vos WM. Microbial functionality in the human intestinal tract. Front Biosci (Landmark Ed) 2009; 14: 3074-3084 [PMID: 19273258]
3. Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc 2014; 89: 107-114 [PMID: 24388028 DOI: 10.1016/j.mayocp.2013.10.011]
4. Zoetendal EG, Vaughan EE, de Vos WM. A microbial world within us. Mol Microbiol 2006; 59: 1639-1650 [PMID: 16553872 DOI: 10.1111/j.1365-2958.2006.05056.x]
5. Borody TJ, Campbell J. Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin North Am 2012; 41: 781-803 [PMID: 23101687 DOI: 10.1016/j.gtc.2012.08.008]
6. Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, Versalovic J, Young V, Finlay BB. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12: 611-622 [PMID: 23159051 DOI: 10.1016/j.chom.2012.10.012]
7. Tappenden KA, Deutsch AS. The physiological relevance of the intestinal microbiota - contributions to human health. J Am Coll Nutr 2007; 26: 679S-683S [PMID: 18187433]
8. Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev 2012; 70 Suppl 1: S10-S13 [PMID: 22861801 DOI: 10.1111/j.1753-4887.2012.00499.x]
9. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-227 [PMID: 22699611 DOI: 10.1038/nature11053]
10. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121: 2126-2132 [PMID: 21633181 DOI: 10.1172/JCI58109]
11. Zhao L. The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 2013; 11: 639-647 [PMID: 23912213 DOI: 10.1038/nrmicro3089]
12. Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol 2013; 25: 488-795 [PMID: 23656715 DOI: 10.1097/BOR.0b013e32836208de]
13. Luckey D, Gomez A, Murray J, White B, Taneja V. Bugs & amp; us: the role of the gut in autoimmunity. Indian J Med Res 2013; 138: 732-743 [PMID: 24434325]
14. Russell SL, Finlay BB. The impact of gut microbes in allergic diseases. Curr Opin Gastroenterol 2012; 28: 563-569 [PMID: 23010680 DOI: 10.1097/MOG.0b013e3283573017]
15. Gold JS, Bayar S, Salem RR. Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg 2004; 139: 760-765 [PMID: 15249410 DOI: 10.1001/archsurg.139.7.760]
16. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1755; author reply p.1755-p.1756 [PMID: 23160295]
17. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854-859 [PMID: 13592638]
18. Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, Kuijper EJ, Wilcox MH. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23: 529-549 [PMID: 20610822 DOI: 10.1128/CMR.00082-09]
19. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med 2008; 359: 1932-1940 [PMID: 18971494 DOI: 10.1056/NEJMra0707500]
20. van Nood E, Speelman P, Nieuwdorp M, Keller J. Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 2014; 30: 34-39 [PMID: 24241245 DOI: 10.1097/MOG.0000000000000024]
21. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002 [PMID: 22002980 DOI: 10.1093/cid/cir632]
22. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2013; 11: 1036-1038 [PMID: 23669309 DOI: 10.1016/j.cgh.2013.04.045]
23. Zanella Terrier MC, Simonet ML, Bichard P, Frossard JL. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota. World J Gastroenterol 2014; 20: 7416-7423 [PMID: 24966611 DOI: 10.3748/wjg.v20.i23.7416]
24. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012; 9: 88-96 [PMID: 22183182 DOI: 10.1038/nrgastro.2011.244]
25. Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014; 68: 363-368 [PMID: 24372725 DOI: 10.1111/ijcp.12320]
26. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761-767 [PMID: 22290405 DOI: 10.1038/ajg.2011.482]
27. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-498; quiz 499 [PMID: 23439232 DOI: 10.1038/ajg.2013.4]
28. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323 [PMID: 19343057 DOI: 10.1038/nri2515]
29. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-360 [PMID: 20048681 DOI: 10.1097/MCG.0b013e3181c87e02]
30. Walker AW, Lawley TD. Therapeutic modulation of intestinal dysbiosis. Pharmacol Res 2013; 69: 75-86 [PMID: 23017673 DOI: 10.1016/j.phrs.2012.09.008]
31. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332: 974-977 [PMID: 21512004 DOI: 10.1126/science.1206095]
32. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337-341 [PMID: 21205640 DOI: 10.1126/science.1198469]
33. Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, Zoetendal EG, de Vos WM. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J 2014; 8: 1621-1633 [PMID: 24577353 DOI: 10.1038/ismej.2014.13]
34. Allegretti JR, Hamilton MJ. Restoring the gut microbiome for the treatment of inflammatory bowel diseases. World J Gastroenterol 2014; 20: 3468-3474 [PMID: 24707129 DOI: 10.3748/wjg.v20.i13.3468]
35. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012; 36: 503-516 [PMID: 22827693 DOI: 10.1111/j.1365-2036.2012.05220.x]
36. Kunde S, Pham A, Bonczyk S, Crumb T, Duba M, Conrad H, Cloney D, Kugathasan S. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 56: 597-601 [PMID: 23542823 DOI: 10.1097/MPG.0b013e318292fa0d]
37. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013; 108: 1620-1630 [PMID: 24060759 DOI: 10.1038/ajg.2013.257]
38. Borody TJ, Finlayson S, Paramsothy S. Is Crohn's disease ready for fecal microbiota transplantation? J Clin Gastroenterol 2014; 48: 582-583 [PMID: 24828361 DOI: 10.1097/mcg.0000000000000155]
39. Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol 2013; 19: 7213-7216 [PMID: 24222969 DOI: 10.3748/wjg.v19.i41.7213]
40. Kao D, Hotte N, Gillevet P, Madsen K. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 2014; 48: 625-628 [PMID: 24667590 DOI: 10.1097/mcg.0000000000000131]
41. Gordon H, Harbord M. A patient with severe Crohn's colitis responds to Faecal Microbiota Transplantation. J Crohns Colitis 2014; 8 : 256-257 [PMID: 24239403 DOI: 10.1016/j.crohns.2013.10.007]
42. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15: 337 [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1]
43. Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989; 150: 604 [PMID: 2783214]
44. Hohmann EL, Ananthakrishnan AN, Deshpande V. Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med 2014; 371: 668-675 [PMID: 25119613 DOI: 10.1056/NEJMcpc1400842]
45. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904 [PMID: 20664075 DOI: 10.1152/physrev.00045.2009]
46. Pennisi E. Mysteries of development. How do microbes shape animal development? Science 2013; 340: 1159-1160 [PMID: 23744921 DOI: 10.1126/science.340.6137.1159]
47. Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38: 1-12 [PMID: 24370461 DOI: 10.1016/j.bbi.2013.12.015]
48. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136 : 2003-2014 [PMID: 19457424 DOI: 10.1053/j.gastro.2009.01.075]
49. Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 2013; 29: 79-84 [PMID: 23041678 DOI: 10.1097/MOG.0b013e32835a4b3e]
50. Ueki A, Otsuka M. Life style risks of Parkinson's disease: association between decreased water intake and constipation. J Neurol 2004; 251 Suppl 7: vII18-vII23 [PMID: 15505750]
51. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, Ross PR, O'Doherty RM, Shanahan F. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010; 59: 1635-1642 [PMID: 20926643 DOI: 10.1136/gut.2010.215665]
52. Parks BW, Nam E, Org E, Kostem E, Norheim F, Hui ST, Pan C, Civelek M, Rau CD, Bennett BJ, Mehrabian M, Ursell LK, He A, Castellani LW, Zinker B, Kirby M, Drake TA, Drevon CA, Knight R, Gargalovic P, Kirchgessner T, Eskin E, Lusis AJ. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab 2013; 17: 141-152 [PMID: 23312289 DOI: 10.1016/j.cmet.2012.12.007]
53. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci USA 2012; 109: 594-599 [PMID: 22184244 DOI: 10.1073/pnas.1116053109]
54. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, Egholm M, Henrissat B, Heath AC, Knight R, Gordon JI. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-484 [PMID: 19043404 DOI: 10.1038/nature07540]
55. Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, Hardt PD. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18: 190-195 [PMID: 19498350 DOI: 10.1038/oby.2009.167]
56. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009; 4: e7125 [PMID: 19774074 DOI: 10.1371/journal.pone.0007125]
57. Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 2012; 32: 637-647 [PMID: 23084636 DOI: 10.1016/j.nutres.2012.07.003]
58. Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, Groen AK, Hoekstra JB, Stroes ES, Nieuwdorp M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14: 112-120 [PMID: 21812894 DOI: 10.1111/j.1463-1326.2011.01483.x]
59. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490: 55-60 [PMID: 23023125 DOI: 10.1038/nature11450]
60. Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M. Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus. Clin Exp Immunol 2014; 177: 24-29 [PMID: 24528224 DOI: 10.1111/cei.12293]
61. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB, Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-916.e7 [PMID: 22728514 DOI: 10.1053/j.gastro.2012.06.031]
62. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63 [PMID: 21475195 DOI: 10.1038/nature09922]
63. Troseid M, Manner IW, Pedersen KK, Haissman JM, Kvale D, Nielsen SD. Microbial translocation and cardiometabolic risk factors in HIV infection. AIDS Res Hum Retroviruses 2014; 30: 514-522 [PMID: 24521167 DOI: 10.1089/aid.2013.0280]
64. Tuohy KM, Fava F, Viola R. 'The way to a man's heart is through his gut microbiota' - dietary pro- and prebiotics for the management of cardiovascular risk. Proc Nutr Soc 2014; 73: 172-185 [PMID: 24495527 DOI: 10.1017/s0029665113003911]
65. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013; 368: 1575-1584 [PMID: 23614584 DOI: 10.1056/NEJMoa1109400]
66. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013; 19: 576-585 [PMID: 23563705 DOI: 10.1038/nm.3145]
67. Wang Z, Tang WH, Buffa JA, Fu X, Britt EB, Koeth RA, Levison BS, Fan Y, Wu Y, Hazen SL. Prognostic value of choline and betaine depends on intestinal microbiotagenerated metabolite trimethylamine-N-oxide. Eur Heart J 2014; 35: 904-910 [PMID: 24497336 DOI: 10.1093/eurheartj/ehu002]
68. Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A, Perlemuter G, Cassard-Doulcier AM, Gérard P. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 2013; 62: 1787-1794 [PMID: 23197411 DOI: 10.1136/gutjnl-2012-303816]
69. Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 2011; 31: 15-31 [PMID: 21568707 DOI: 10.1146/annurev-nutr-072610-145146]
70. Abu-Shanab A, Quigley EM. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2010; 7: 691-701 [PMID: 21045794 DOI: 10.1038/nrgastro.2010.172]
71. Bugianesi E, Moscatiello S, Ciaravella MF, Marchesini G. Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des 2010; 16: 1941-1951 [PMID: 20370677]
72. Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 2014; 146: 1513-1524 [PMID: 24440671 DOI: 10.1053/j.gastro.2014.01.020]
73. Rabot S, Membrez M, Bruneau A, Gérard P, Harach T, Moser M, Raymond F, Mansourian R, Chou CJ. Germfree C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 2010; 24: 4948-4959 [PMID: 20724524 DOI: 10.1096/fj.10-164921]
74. Ananthaswamy A . Faecal transplant eases symptoms of Parkinson's disease. New Sci 2011; 209: 8-9
75. Guseo A . [The Parkinson puzzle]. Orv Hetil 2012; 153: 2060-2069 [PMID: 23261994 DOI: 10.1556/oh.2012.29461]
76. Borody TJ, Leis SM, Campbell J, Torres M, Nowak A. Fecal microbiota transplantation (FMT) in multiple sclerosis (MS) [abstract]. Am J Gastroenterol 2011; 106: S352
77. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122: 107-118 [PMID: 16009137 DOI: 10.1016/j.cell.2005.05.007]
78. Borody TJ, Rosen DM, Torres M, Campbell J, Nowak A. Myoclonus-dystonia (M-D) mediated by GI microbiota diarrhoea treatment improves M-D symptoms. Am J Gastroenterol 2011; 106: S352
79. Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A. Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002; 35: S6-S16 [PMID: 12173102]
80. Finegold SM. State of the art; microbiology in health and disease. Intestinal bacterial flora in autism. Anaerobe 2011; 17: 367-368 [PMID: 21524713 DOI: 10.1016/j.anaerobe.2011.03.007]
81. Goodwin MS, Cowen MA, Goodwin TC. Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children. J Autism Child Schizophr 1971; 1: 48-62 [PMID: 5172439]
82. Song Y, Liu C, Finegold SM. Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 2004; 70: 6459-6465 [PMID: 15528506 DOI: 10.1128/aem.70.11.6459-6465.2004]
83. Frémont M, Coomans D, Massart S, De Meirleir K. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe 2013; 22: 50-56 [PMID: 23791918 DOI: 10.1016/j.anaerobe.2013.06.002]
84. Borody TJ, Nowak A, Finlayson S. The GI microbiome and its role in chronic fatigue syndrome: A summary of bacteriotherapy. J Australas Coll Nutr Env Med 2012; 31: 3
85. Borody TJ, Campbell J, Torres M, Nowak A, Leis S. Reversal of idiopathic thrombocytopenic purpura (ITP) with fecal microbiota transplantation (FMT) [abstract]. Am J Gastroenterol 2011; 106: S352
86. Abdollahi-Roodsaz S, Rogier R, Ederveen T, Wopereis H, Oozeer R, Koenders M, van den Berg W. Commensal intestinal microbiota drives spontaneous interleukin-1-and T helper 17-mediated arthritis in mice. Ann Rheum Dis 2014; 73 (Suppl 1): A87-A88
87. Yeoh N, Burton JP, Suppiah P, Reid G, Stebbings S. The role of the microbiome in rheumatic diseases. Curr Rheumatol Rep 2013; 15: 314 [PMID: 23378145 DOI: 10.1007/s11926-012-0314-y]
88. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2: e01202 [PMID: 24192039 DOI: 10.7554/eLife.01202]
89. Kyriakidis NC, Kapsogeorgou EK, Tzioufas AG. A comprehensive review of autoantibodies in primary Sjögren' s syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun 2014; 51: 67-74 [PMID: 24333103 DOI: 10.1016/j.jaut.2013.11.001]
90. Menéndez A, Gómez J, Caminal-Montero L, Díaz-López JB, Cabezas-Rodríguez I, Mozo L. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus. Scientific World Journal 2013; 2013: 832789 [PMID: 24294139 DOI: 10.1155/2013/832789]
91. Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US. T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol 2014; 152: 1-9 [PMID: 24576620 DOI: 10.1016/j.clim.2014.02.004]
92. Strieder TG, Wenzel BE, Prummel MF, Tijssen JG, Wiersinga WM. Increased prevalence of antibodies to enteropathogenic Yersinia enterocolitica virulence proteins in relatives of patients with autoimmune thyroid disease. Clin Exp Immunol 2003; 132: 278-282 [PMID: 12699417]
93. Corapçioʇlu D, Tonyukuk V, Kiyan M, Yilmaz AE, Emral R, Kamel N, Erdoʇan G. Relationship between thyroid autoimmunity and Yersinia enterocolitica antibodies. Thyroid 2002; 12: 613-617 [PMID: 12193307 DOI: 10.1089/105072502320288483]
94. Mori K, Nakagawa Y, Ozaki H. Does the gut microbiota trigger Hashimoto's thyroiditis? Discov Med 2012; 14: 321-326 [PMID: 23200063]
95. Effraimidis G, Tijssen JG, Strieder TG, Wiersinga WM. No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol 2011; 165: 38-43 [PMID: 21488870 DOI: 10.1111/j.1365-2249.2011.04399.x]
96. Sasso FC, Carbonara O, Torella R, Mezzogiorno A, Esposito V, Demagistris L, Secondulfo M, Carratú R, Iafusco D, Cartenì M. Ultrastructural changes in enterocytes in subjects with Hashimoto's thyroiditis. Gut 2004; 53: 1878-1880 [PMID: 15542532 DOI: 10.1136/gut.2004.047498]
97. Reynolds LA, Finlay BB. A case for antibiotic perturbation of the microbiota leading to allergy development. Expert Rev Clin Immunol 2013; 9: 1019-1030 [PMID: 24168410 DOI: 10.1586/1744666X.2013.851603]
98. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260 [PMID: 2513902]
99. Noverr MC, Huffnagle GB. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy 2005; 35: 1511-1520 [PMID: 16393316 DOI: 10.1111/j.1365-2222.2005.02379.x]
100. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, Blumberg RS. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489-493 [PMID: 22442383]
101. Herbst T, Sichelstiel A, Schär C, Yadava K, Bürki K, Cahenzli J, McCoy K, Marsland BJ, Harris NL. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 2011; 184: 198-205 [PMID: 21471101 DOI: 10.1164/rccm.201010-1574OC]
102. Stensballe LG, Simonsen J, Jensen SM, Bonnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013; 162: 832-838.e3 [PMID: 23140881 DOI: 10.1016/j.jpeds.2012.09.049]
103. Goksör E, Alm B, Pettersson R, Möllborg P, Erdes L, Aberg N, Wennergren G. Early fish introduction and neonatal antibiotics affect the risk of asthma into school age. Pediatr Allergy Immunol 2013; 24: 339-344 [PMID: 23577718 DOI: 10.1111/pai.12078]
104. Jang SO, Kim HJ, Kim YJ, Kang MJ, Kwon JW, Seo JH, Kim HY, Kim BJ, Yu J, Hong SJ. Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells. Allergy Asthma Immunol Res 2012; 4: 150-156 [PMID: 22548208 DOI: 10.4168/aair.2012.4.3.150]
105. Schabussova I, Hufnagl K, Tang ML, Hoflehner E, Wagner A, Loupal G, Nutten S, Zuercher A, Mercenier A, Wiedermann U. Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One 2012; 7: e40271 [PMID: 22792257 DOI: 10.1371/journal.pone.0040271]
106. Fiocchi A, Burks W, Bahna SL, Bielory L, Boyle RJ, Cocco R, Dreborg S, Goodman R, Kuitunen M, Haahtela T, Heine RG, Lack G, Osborn DA, Sampson H, Tannock GW, Lee BW. Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. World Allergy Organ J 2012; 5: 148-167 [PMID: 23282383 DOI: 10.1097/WOX.0b013e3182784ee0]
107. Dotterud CK, Storro O, Johnsen R, Oien T. Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol 2010; 163: 616-623 [PMID: 20545688 DOI: 10.1111/j.1365-2133.2010.09889.x]
108. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013; 105: 1907-1911 [PMID: 24316595 DOI: 10.1093/jnci/djt300]
109. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14: 207-215 [PMID: 23954159 DOI: 10.1016/j.chom.2013.07.007]
110. Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res 2014; 20: 859-867 [PMID: 24334760 DOI: 10.1158/1078-0432.ccr-13-1343]
111. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG, Erdman SE. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res 2006; 66: 57-61 [PMID: 16397216 DOI: 10.1158/0008-5472.can-05-3445]
112. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006; 66: 7395-7400 [PMID: 16885333 DOI: 10.1158/0008-5472.can-06-0558]
113. Rao VP, Poutahidis T, Fox JG, Erdman SE. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res 2007; 67: 847-850 [PMID: 17283110 DOI: 10.1158/0008-5472.can-06-3468]
114. Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, Williams M, McFaline JL, Essigmann JM, Schauer DB, Tannenbaum SR, Dedon PC, Weinman SA, Lemon SM, Fry RC, Rogers AB. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010; 59: 88-97 [PMID: 19850960 DOI: 10.1136/gut.2009.183749]
115. Yamamoto ML, Maier I, Dang AT, Berry D, Liu J, Ruegger PM, Yang JI, Soto PA, Presley LL, Reliene R, Westbrook AM, Wei B, Loy A, Chang C, Braun J, Borneman J, Schiestl RH. Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity. Cancer Res 2013; 73: 4222-4232 [PMID: 23860718 DOI: 10.1158/0008-5472.can-13-0022]